Jenke, Robert
Heinrich, Theresa
Lordick, Florian
Aigner, Achim https://orcid.org/0000-0002-2778-6256
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (AI 24/33-1)
Deutsche Forschungsgemeinschaft (AI 24/33-1)
University Hospital and Medical Faculty Leipzig, Clinician Scientist Program
Article History
Received: 16 April 2025
Revised: 22 July 2025
Accepted: 12 August 2025
First Online: 22 August 2025
Competing interests
: Dr. Lordick reports research grants for his institution from AstraZeneca, Beigene, BMS, Daiichi Sankyo, and Gilead, and personal fees from: Amgen, ArtTempi. Astellas, Astra Zeneca, Bayer, BMS, Boehringer Ingelheim, Iomedico, Daiichi Sankyo, Eli Lilly, Gilead, Elsevier, Incyte, Medscape, MedUpdate, Merck Serono, MSD, PAGE, Roche, Servier, StreamedUp!, VJ Oncology, all outside the submitted work. Dr. Aigner reports personal fees from SiSaf, De Gruyter, and Elsevier, all outside the submitted work.
: This is to confirm that all methods were performed in accordance with the relevant guidelines and regulations. This publication does not include studies on live vertebrates or humans. Thus, (written) informed consent does not apply.